G. Follea et al., COMPARATIVE VALIDATION OF MANUAL AND AUTO MATED METHODS FOR MIXING AND VOLUME CONTROL IN WHOLE-BLOOD COLLECTION, Transfusion clinique et biologique, 4(4), 1997, pp. 391-402
During blood collection, agitation and volume limitations are critical
to ensure thorough mixing of the blood with the anticoagulant and obt
ention of the predetermined volume. These 2 factors are essential to p
revent blood activation and to obtain well standardized blood products
. The objective of this study was to compare the quality of the blood
collected using 2 types of collection method: tripping of a scale at a
predetermined volume limit of 450 mt in the presence of manual agitat
ion, and the 3 blood collection monitors currently available in France
. A minimum of 100 collection procedures was performed for each of the
4 methods tested. Results were found to be equivalent using either th
e manual or the automated procedures with regard to both the accuracy
and reproducibility of the blood volumes obtained and the collection t
imes and flow rates. The characteristics of the red blood cell concent
rates, platelet concentrates and plasma units prepared from the first
30 collections of each group were assessed and compared to regulatory
requirements. The quality of all these products was found to be compar
able to that currently observed at quality control and no product was
rejected at the release control for reasons of poor collection. An ass
essment of the practicability of the different methods showed that the
automated devices are subject to practical difficulties involving tra
nsport and battery loading. in addition, the cost of this equipment is
approximately 5 times higher than that of the scales. Ln conclusion,
the results of this study show that in our hands, no significant advan
tage could be expected from the use of automated blood collection moni
tors as compared to simple scales with manual mixing. These results fu
rther raise the question of the applicability to labile blood products
of the comparative validations currently accepted in the pharmaceutic
al industry in order to allow the use of correctly validated alternati
ve methods.